Effects of 900 MHz GSM Wireless Communication Signals on DMBA-Induced Mammary Tumors in Rats

Abstract Yu, D., Shen, Y. H., Kuster, N., Fu, Y. T. and Chiang, H. Effects of 900 MHz GSM Wireless Communication Signals on DMBA-Induced Mammary Tumors in Rats. Radiat. Res. 165, 174–180 (2006). The purpose of the study was to investigate whether exposure to 900 MHz GSM wireless communication signals enhances mammary tumor development and growth induced by low-dose DMBA. Five hundred female Sprague-Dawley rats were treated with a single dose of 35 mg/kg DMBA and then divided into five groups in a blinded fashion: one cage control group and four exposure groups, including three microwave exposure groups and one sham exposure with specific absorption rates (SARs) of 4.0, 1.33, 0.44 and 0 W/kg, respectively. Exposure started on the day after DMBA administration and lasted 4 h/day, 5 days/week for 26 weeks. Rats were weighed and palpated weekly for the presence of tumors and were killed humanely at the end of the 26-week exposure period. All mammary glands were examined histologically. There were no statistically significant differences in body weight between sham- and GSM microwave-exposed groups. No significant differences in overall mammary tumor incidence, latency to tumor onset, tumor multiplicity, or tumor size were observed between microwave- and sham-exposed groups. There was a tendency for reduction of mammary adenocarcinoma incidence in the lowest microwave exposure group (0.44 W/ kg) compared with the sham-exposed group (P = 0.058). Additionally, a higher incidence of adenocarcinoma was noticed in the 4.0 W/kg group from the 15th to 26th weeks, especially in the 19th week (P = 0.358 compared to sham). However, neither tendency was statistically significant; thus this study does not provide evidence that GSM microwave exposure promotes mammary tumor development in rats. In the present study there were significant differences between the cage controls and the experimental groups (sham and exposure). Body weight and mammary tumor (malignant plus benign) incidence in the cage control group were significantly higher than in the sham- and GSM microwave-exposed groups. The latency to the mammary tumor onset was significantly shorter in the cage control group than in the other groups.

[1]  K. Ryan,et al.  Repeated Exposure of C3H/HeJ Mice to Ultra-wideband Electromagnetic Pulses: Lack of Effects on Mammary Tumors , 2001, Radiation research.

[2]  M. Repacholi Low-level exposure to radiofrequency electromagnetic fields: health effects and research needs. , 1998, Bioelectromagnetics.

[3]  L. E. Anderson,et al.  Effect of 13 week magnetic field exposures on DMBA-initiated mammary gland carcinomas in female Sprague–Dawley rats , 1999, Carcinogenesis.

[4]  G A Boorman,et al.  Effect of 26 week magnetic field exposures in a DMBA initiation–promotion mammary gland model in Sprague–Dawley rats , 1999, Carcinogenesis.

[5]  R. Stevens,et al.  Electric power use and breast cancer: a hypothesis. , 1987, American journal of epidemiology.

[6]  R Kavet,et al.  Testing electromagnetic fields for potential carcinogenic activity: a critical review of animal models. , 1997, Environmental health perspectives.

[7]  B. Veyret,et al.  No effect of short-term exposure to GSM-modulated low-power microwaves on benzo(a)pyrene-induced tumours in rat. , 1999, International journal of radiation biology.

[8]  M. Geffard,et al.  Effects of GSM-900 Microwaves on DMBA-Induced Mammary Gland Tumors in Female Sprague-Dawley Rats , 2003, Radiation research.

[9]  O. Tulp,et al.  Reduction of Enhanced Mammary Carcinogenesis in LA/N-cp (Corpulent) Rats by Energy Restriction , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[10]  M A Stedham,et al.  Chronic, low-level (1.0 W/kg) exposure of mice prone to mammary cancer to 2450 MHz microwaves. , 1998, Radiation research.

[11]  D Krewski,et al.  Potential health risks of radiofrequency fields from wireless telecommunication devices. , 2001, Journal of toxicology and environmental health. Part B, Critical reviews.

[12]  M. Geffard,et al.  Effects of GSM‐900 microwaves on the experimental allergic encephalomyelitis (EAE) rat model of multiple sclerosis , 2003, Bioelectromagnetics.

[13]  R. Gebhard,et al.  Inhibition of mammary carcinogenesis in rats by dietary restriction. , 1988, Cancer letters.

[14]  W. Löscher,et al.  Acceleration of mammary tumorigenesis by exposure of 7,12-dimethylbenz[a]anthracene-treated female rats in a 50-Hz, 100-microT magnetic field: replication study. , 1998, Journal of toxicology and environmental health. Part A.

[15]  B. Shao,et al.  The effects of 50 Hz magnetic field exposure on dimethylbenz(alpha)anthracene induced thymic lymphoma/leukemia in mice. , 1997, Bioelectromagnetics.

[16]  A Basten,et al.  Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. , 1997, Radiation research.

[17]  W. Löscher,et al.  Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer. , 1999, Cancer research.

[18]  N Kuster,et al.  Recommended minimal requirements and development guidelines for exposure setups of bio-experiments addressing the health risk concern of wireless communications. , 2000, Bioelectromagnetics.

[19]  D A Savitz,et al.  Breast cancer mortality among female electrical workers in the United States. , 1994, Journal of the National Cancer Institute.

[20]  W. Löscher,et al.  Seasonal influence on 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in Sprague-Dawley rats under controlled laboratory conditions. , 1997, Pharmacology & toxicology.

[21]  J. H. Merritt,et al.  Chronic exposure of cancer-prone mice to low-level 2450 MHz radiofrequency radiation. , 1998, Bioelectromagnetics.

[22]  B. Shao,et al.  Effects of 2.45-GHz microwave radiation and phorbol ester 12-O-tetradecanoylphorbol-13-acetate on dimethylhydrazine-induced colon cancer in mice. , 1994, Bioelectromagnetics.

[23]  J. J. Broerse,et al.  Differences in DMBA-induced mammary neoplastic responses in two lines of Sprague-Dawley rats. , 1984, European journal of cancer & clinical oncology.

[24]  F. Labrie,et al.  Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat. , 1989, European journal of cancer & clinical oncology.

[25]  J E Moulder,et al.  Cell phones and cancer: what is the evidence for a connection? , 1999, Radiation research.

[26]  C Bartsch,et al.  Chronic Exposure to a GSM-like Signal (Mobile Phone) Does Not Stimulate the Development of DMBA-Induced Mammary Tumors in Rats: Results of Three Consecutive Studies , 2002, Radiation research.

[27]  M. Repacholi,et al.  More research is needed to determine the safety of static magnetic fields. , 2005, Progress in biophysics and molecular biology.

[28]  S. Szmigielski,et al.  Accelerated development of spontaneous and benzopyrene-induced skin cancer in mice exposed to 2450-MHz microwave radiation. , 1982, Bioelectromagnetics.

[29]  International classification of rodent tumours. Part I--The rat. 6. Endocrine system. , 1994, IARC scientific publications.